Article Text

Download PDFPDF
8th European Conference on Clinical Aspects and Treatment of HIV Infection, Athens, 28–31 October 2001
  1. Adrian Palfreeman1,
  2. Mia Huengsberg2
  1. 1Department of GU Medicine, Peterborough District Hospital, Peterborough PE3 6DA, UK
  2. 2Whittall Street Clinic, Birmingham B4 6DH, UK

    Statistics from

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    The conference was set in the Astir Hotel Resort on the peninsula at the outskirts of Athens, overlooking the Phaleron Bay. It was officially opened by Dr Christine Katlama, president of the European AIDS Clinical Society, and Professor John Kosmidis, the conference chairman. The European Clinical Guidelines for HIV management, written by the European AIDS Clinical Society (EACS), was launched at the conference.

    The main focus of many delegates was on new antiretroviral drugs. The star of the conference was tenofovir disoproxil fumarate, a single tablet, once daily nucleotide developed by Gilead Sciences. It has potent activity against multidrug nucleoside resistant HIV, with the exception of T69 insertion, which is fortunately rare (1% of all patients). At 24 weeks, adding tenofovir …

    View Full Text